We are live on ! Find out more
CAM

ClariVest Asset Management Portfolio holdings

AUM $980M
1-Year Est. Return 60.89%
This Fund
S&P 500
This Quarter Est. Return
+12.64%
1 Year Est. Return
+60.89%
3 Year Est. Return
+106.43%
5 Year Est. Return
+337.88%
10 Year Est. Return
+1,091.18%
AUM
$3B
AUM Growth
+$175M
Cap. Flow
-$110M
Cap. Flow %
-3.66%
Top 10 Hldgs %
32.91%
Holding
863
New
116
Increased
124
Reduced
210
Closed
111

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$25.1M
2
LLY icon
Eli Lilly
LLY
+$17M
3
PG icon
Procter & Gamble
PG
+$14.3M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$11.5M
5
EBAY icon
eBay
EBAY
+$10.9M

Sector Composition

Rank Sector Weight
1 Technology 34.15%
2 Consumer Discretionary 18.06%
3 Healthcare 13.51%
4 Communication Services 9.6%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
F icon
401
Ford
F
$55.7B
$605K 0.02%
40,729
LBC
402
DELISTED
Luther Burbank Corporation Common Stock
LBC
$602K 0.02%
50,937
-433
-0.8% -$5.11K
NTLA icon
403
Intellia Therapeutics
NTLA
$1.67B
$598K 0.02%
+3,694
New +$288K
ROKU icon
404
Roku
ROKU
$22.7B
$598K 0.02%
1,303
CLS icon
405
Celestica
CLS
$36.5B
$595K 0.02%
75,800
MDC
406
DELISTED
M.D.C. Holdings, Inc.
MDC
$593K 0.02%
11,706
-7
-0.1% -$401
VEDL
407
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$588K 0.02%
41,400
ARNA
408
DELISTED
Arena Pharmaceuticals Inc
ARNA
$587K 0.02%
8,618
-2,550
-23% -$166K
FBC
409
DELISTED
Flagstar Bancorp, Inc. New
FBC
$587K 0.02%
13,884
-63
-0.5% -$2.85K
LNC icon
410
Lincoln National
LNC
$8.81B
$586K 0.02%
9,323
HWKN icon
411
Hawkins
HWKN
$2.71B
$583K 0.02%
17,800
-18
-0.1% -$596
CSBR icon
412
Champions Oncology
CSBR
$72.1M
$582K 0.02%
56,600
STL
413
DELISTED
Sterling Bancorp
STL
$578K 0.02%
23,308
HRB icon
414
H&R Block
HRB
$5.86B
$576K 0.02%
24,524
-265
-1% -$6.27K
KN icon
415
Knowles
KN
$3.34B
$575K 0.02%
29,088
+65
+0.2% +$1.32K
PNFP icon
416
Pinnacle Financial Partners Inc
PNFP
$15.8B
$574K 0.02%
6,500
-18
-0.3% -$1.61K
MSTR icon
417
Strategy Inc
MSTR
$38.4B
$572K 0.02%
+8,610
New +$509K
BHF icon
418
Brighthouse Financial
BHF
$3.5B
$561K 0.02%
12,321
UPBD icon
419
Upbound Group
UPBD
$1.16B
$559K 0.02%
10,539
-95
-0.9% -$5.52K
ISRG icon
420
Intuitive Surgical
ISRG
$134B
$552K 0.02%
+1,800
New +$505K
NMRK icon
421
Newmark Group
NMRK
$2.63B
$545K 0.02%
45,400
TGTX icon
422
TG Therapeutics
TGTX
$7.62B
$534K 0.02%
13,790
+30
+0.2% +$1.18K
AGCO icon
423
AGCO
AGCO
$7.2B
$532K 0.02%
4,073
-7
-0.2% -$985
WCC
424
WESCO International
WCC
$17.7B
$531K 0.02%
5,168
-14
-0.3% -$1.39K
FSTR icon
425
Foster
FSTR
$432M
$521K 0.02%
28,000

Similar funds

ClariVest Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, ClariVest Asset Management held 863 positions worth $3B, up 6.2% from $2.83B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

ClariVest Asset Management withdrew a net $110M in Q2 2021, closing 111 positions and reducing 210 holdings. Its most notable exit was Amgen, an estimated $25.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, ClariVest Asset Management opened a new position in Charles Schwab worth $15M.

  • ClariVest Asset Management's largest Q2 2021 buy was Charles Schwab: 206,235 shares worth $15M.
  • ClariVest Asset Management added most to Olin in Q2 2021, an estimated $13.5M increase.
  • ClariVest Asset Management's biggest Q2 2021 reduction was Eli Lilly, cutting an estimated $17M.
  • ClariVest Asset Management fully exited Amgen in Q2 2021, selling an estimated $25.1M.
  • ClariVest Asset Management's ten largest holdings make up 33% of its $3B portfolio in Q2 2021.
  • ClariVest Asset Management opened 116 new positions and closed 111 in Q2 2021.
  • ClariVest Asset Management's portfolio value rose 6.2% quarter-over-quarter to $3B.

Based on ClariVest Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.